Logo

American Heart Association

  99
  0


Final ID:

Discussant

  • Sauer, Andrew  ( Saint Lukes Mid America Heart Inst , Kansas City , Missouri , United States )
  • Author Disclosures:
    Andrew Sauer: DO have relevant financial relationships ; Advisor:Bayer:Active (exists now) ; Advisor:Edwards:Active (exists now) ; Researcher:Edwards:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Researcher:Abbott:Active (exists now) ; Researcher:Boston Scientific:Active (exists now) ; Researcher:Vifor:Active (exists now) ; Researcher:AstraZeneca:Active (exists now) ; Advisor:Acorai:Active (exists now) ; Researcher:Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

From Madrid to Mardi Gras: Heart Failure Trials on Parade

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Efficacy and safety of Digitoxin in heart failure with reduced ejection fraction according to age: Insights from DIGIT-HF

Bavendiek Udo, Huelsmann Martin, Von Der Leyen Heiko, Veltmann Christian, Stork Stefan, Boehm Michael, Koch Armin, Bauersachs Johann, Berliner Dominik, Thomas Nele, Grosshennig Anika, Schwab Johannes, Rieth Andreas, Maier Lars, Gaspar Thomas, Zdravkovic Marija

SOTA-P-CARDIA Trial (ATRU-V). A Randomized Trial of Sotagliflozin in HFpEF patients without diabetes.

Badimon Juan, Lam David, Abascal Vivian, Lerakis Stamatios, Mancini Donna, Sartori Samantha, Requena Juan Antonio, Santos-gallego Carlos, Ferrandez Marcos, Zafar Mohammad, Angermann Christiane, Fuster Valentin, Lajam Farah, Fergus Icilma

More abstracts from these authors:
Multisystem pathology of HFpEF in obesity

Shah Sanjiv, Lewis Gregory, Sauer Andrew


Revolutionizing the Electronic Medical Record to Optimize GDMT

Sauer Andrew, Morris Alanna

You have to be authorized to contact abstract author. Please, Login
Not Available